|
Originally published In Press as doi:10.1074/jbc.M201076200 on March 21, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22656-22661, June 21, 2002
The Major Conformational IgE-binding Epitopes of
Hevein (Hev b6.02) Are Identified by a Novel Chimera-based Allergen
Epitope Mapping Strategy*
Piia
Karisola ,
Harri
Alenius§,
Jari
Mikkola§,
Nisse
Kalkkinen¶,
Jari
Helin¶,
Olli T.
Pentikäinen ,
Susanna
Repo ,
Timo
Reunala**,
Kristiina
Turjanmaa**,
Mark S.
Johnson ,
Timo
Palosuo , and
Markku S.
Kulomaa §§
From the Department of Biological and Environmental
Science, University of Jyväskylä, P. O. Box 35 (YAB),
FIN-40014 University of Jyv skyl , Finland,
§ Finnish Institute of Occupational Health, Topeliuksenkatu
42 aA, FIN-00250 Helsinki, Finland, ¶ Institute of
Biotechnology, University of Helsinki, P. O. Box 56, FIN-00014
University of Helsinki, Helsinki, Finland, Department of
Biochemistry and Pharmacy, Åbo Akademi University, P. O. Box 66, FIN-20521 Turku, Finland, ** University Hospital of Tampere,
P. O. Box 2000, FIN-33521 Tampere, Finland, and
 National Public Health Institute,
Mannerheimintie 166, FIN-00300 Helsinki, Finland
A novel approach to localize and reconstruct
conformational IgE-binding epitope regions of hevein (Hev b6.02), a
major natural rubber latex allergen, is described. An antimicrobial
protein (AMP) from the amaranth Amaranthus caudatus was
used as an immunologically non-IgE-binding adaptor molecule to which
terminal or central parts of hevein were fused. Hevein and AMP share a
structurally identical core region but have different N-terminal and
C-terminal regions. Only 1 of 16 hevein-allergic patients showed weak
IgE binding to purified native or recombinant AMP. Chimeric AMP with the hevein N terminus was recognized by IgE from 14 (88%) patients, and chimeric AMP with the hevein C terminus was recognized by IgE from
6 (38%) patients. In contrast, chimeric AMP containing the hevein core
region was recognized by IgE from only two patients. When both
the N-terminal and C-terminal regions of hevein were fused with the AMP
core, IgE from all 16 patients bound to the chimera. This chimera was
also able to significantly inhibit (>70%) IgE binding to the native
hevein. On the contrary, linear synthetic peptides corresponding to
hevein regions in the AMP chimeras showed no significant IgE binding
capacity in either enzyme-linked immunosorbent assay or inhibition
enzyme-linked immunosorbent assay. These results suggest that the IgE
binding ability of hevein is essentially determined by its N-terminal
and C-terminal regions and that major IgE-binding epitopes of hevein
are conformational. The chimera-based epitope mapping strategy
described here provides a valuable tool for defining structural
epitopes and creating specific reagents for allergen immunotherapy.
*
This work was supported by Grant 37852 from the Academy of
Finland.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§§
To whom correspondence should be addressed. Tel.:
358-14-260-2272 or 358-500-599-904; Fax: 358-14-260-2221;
E-mail: markku. kulomaa{at}csc.fi.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. C. Drew, N. P. Eusebius, L. Kenins, H. D. de Silva, C. Suphioglu, J. M. Rolland, and R. E. O'Hehir
Hypoallergenic Variants of the Major Latex Allergen Hev b 6.01 Retaining Human T Lymphocyte Reactivity
J. Immunol.,
November 1, 2004;
173(9):
5872 - 5879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Karisola, J. Mikkola, N. Kalkkinen, K. J. Airenne, O. H. Laitinen, S. Repo, O. T. Pentikainen, T. Reunala, K. Turjanmaa, M. S. Johnson, et al.
Construction of Hevein (Hev b 6.02) with Reduced Allergenicity for Immunotherapy of Latex Allergy by Comutation of Six Amino Acid Residues on the Conformational IgE Epitopes
J. Immunol.,
February 15, 2004;
172(4):
2621 - 2628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. H. Laitinen, H. R. Nordlund, V. P. Hytonen, S. T. H. Uotila, A. T. Marttila, J. Savolainen, K. J. Airenne, O. Livnah, E. A. Bayer, M. Wilchek, et al.
Rational Design of an Active Avidin Monomer
J. Biol. Chem.,
January 31, 2003;
278(6):
4010 - 4014.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|